2-(2-(2-(2-Bromoethoxy)ethoxy)ethyl)isoindoline-1,3-dione

Catalog No. :
ACULGO039
CAS No. :
86927-04-0
Molecular Formula :
C14H16BrNO4
Molecular Weight :
342.19

IUPAC Name:2-(2-(2-(2-bromoethoxy)ethoxy)ethyl)isoindoline-1,3-dione

2-(2-(2-(2-Bromoethoxy)ethoxy)ethyl)isoindoline-1,3-dione structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg98%$96.00Login to see priceIn stockInquiry
1g98%$304.00Login to see priceIn stockInquiry
5g98%$1034.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(2-(2-(2-Bromoethoxy)ethoxy)ethyl)isoindoline-1,3-dione
IUPAC Name2-(2-(2-(2-bromoethoxy)ethoxy)ethyl)isoindoline-1,3-dione
Molecular FormulaC14H16BrNO4
Molecular Weight342.19
SMILESO=C1N(CCOCCOCCBr)C(C2=C1C=CC=C2)=O
InChI KeyKDODZOZWGDTABT-UHFFFAOYSA-N
Synonym1H-Isoindole-1,3(2H)-dione, 2-[2-[2-(2-bromoethoxy)ethoxy]ethyl]-;2-(2-(2-(2-bromoethoxy)ethoxy)ethyl)isoindoline-1,3-dione;Phthalimido-PEG2-CH2CH2Br
CAS No.86927-04-0

Safety Data

Pictogram
Corrosive
Signal Word
Danger
Hazard Statement(s)
H290-H314
Precautionary Statement(s)
P234-P260-P264-P280-P301+P330+P331-P303+P361+P353-P304+P340+P310-P305+P351+P338+P310-P363-P390-P405-P406-P501

Synthetic Route by SureRoute

1. ACULGO039 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACHITO174 route compound structure diagram
    ACHITO17431255-10-4 In Stock
  2. Plus
  3. ACJDOI249 route compound structure diagram
    ACJDOI2491074-82-4 In Stock
  4. Then
  5. ACULGO039 route product structure diagram
    ACULGO03986927-04-0 In Stock
Inquiry

2. ACULGO039 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACULGO039 route product structure diagram
    ACULGO03986927-04-0 In Stock
Inquiry

Comments (0)